Societe Generale analyst Florent Cespedes raised the price target on Eli Lilly (NYSE: LLY) to $126.00 (from $106.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE